Merck | MRK - Assets


Merck reported EUR51.53B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Adidas EUR 20.26B 115M Dec/2025
Adyen EUR 13.94B 2.51B Jun/2025
Akzo Nobel EUR 13.95B 55M Dec/2025
Alcon AG USD 31.56B 31M Dec/2025
Amadeus IT EUR 11.47B 108.4M Dec/2025
Amarin USD 670.78M 10.96M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
BASF EUR 76.17B 267M Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Beiersdorf EUR 12.76B 166M Dec/2025
Covestro EUR 13.47B 245M Dec/2025
Danone EUR 45.07B 1.32B Dec/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Fresenius Medical Care EUR 31B 115.33M Dec/2025
Galapagos EUR 3.41B 105.39M Dec/2025
Genmab DKK 12.87B 5.85B Dec/2025
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Henkel EUR 32.53B 258M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Infineon EUR 30.74B 268M Dec/2025
Linde USD 86.82B 824M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Philips EUR 26.94B 605M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 18.16B 971M Dec/2025